Literature DB >> 23566730

Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.

Rachel M Kruer1, Lindsay H Harris, Haley Goodwin, Joshua Kornbluth, Katherine P Thomas, Leigh A Slater, Elliott R Haut.   

Abstract

PURPOSE: Current guidelines for traumatic brain injury (TBI) recommend antiepileptic drugs (AEDs) for 7 days after injury to decrease posttraumatic seizure risk. Phenytoin decreases seizure risk 73% vs placebo during this time. Levetiracetam (LEV) is an alternative; however, no published data validate comparable efficacy. Our objective was to evaluate seizure incidence 7 days after TBI in patients treated with phenytoin (PHT) vs LEV and to characterize practice of AED selection.
METHODS: A retrospective observational study was conducted using a Trauma Registry (Collector Trauma Registry; Digital Innovation, Inc, Forrest Hill, Md) to evaluate patients with TBI. Patients with an initial Head/Neck Abbreviated Injury Scale score of 3 or higher and a Glasgow Coma Scale of 8 or less were included.
RESULTS: Of 109 patients, 89 received PHT, and 20, LEV. Two patients experienced posttraumatic seizure, 1 in each group. Sixty-eight patients survived to hospital discharge; 65% received prophylactic AED greater than 7 days. Ninety-eight percent of 81 patients admitted between 2000 and 2007 received PHT, whereas 64% of 28 patients admitted between 2008 and 2010 received LEV.
CONCLUSION: Only 2 patients experienced posttraumatic seizure after receiving AED, indicating low incidence. Most surviving to hospital discharge received AED prophylaxis greater than 7 days despite guideline recommendations. After approval of intravenous LEV, a trend favoring LEV was observed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Levetiracetam; Phenytoin; Seizure; Seizure prophylaxis; Traumatic brain injury

Mesh:

Substances:

Year:  2013        PMID: 23566730     DOI: 10.1016/j.jcrc.2012.11.020

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  22 in total

Review 1.  Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Authors:  Yong Yang; Fangshuo Zheng; Xin Xu; Xuefeng Wang
Journal:  CNS Drugs       Date:  2016-08       Impact factor: 5.749

2.  Variation in Anticonvulsant Selection and Electroencephalographic Monitoring Following Severe Traumatic Brain Injury in Children-Understanding Resource Availability in Sites Participating in a Comparative Effectiveness Study.

Authors:  Jonathan E Kurz; Samuel M Poloyac; Nicholas S Abend; Anthony Fabio; Michael J Bell; Mark S Wainwright
Journal:  Pediatr Crit Care Med       Date:  2016-07       Impact factor: 3.624

Review 3.  The Neurocritical and Neurosurgical Care of Subdural Hematomas.

Authors:  Kevin T Huang; Wenya Linda Bi; Muhammad Abd-El-Barr; Sandra C Yan; Ian J Tafel; Ian F Dunn; William B Gormley
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

4.  EEG Monitoring and Antiepileptic Drugs in Children with Severe TBI.

Authors:  Christopher M Ruzas; Peter E DeWitt; Kimberly S Bennett; Kevin E Chapman; Nicole Harlaar; Tellen D Bennett
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

5.  Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.

Authors:  Bardiya Zangbar; Mazhar Khalil; Angelika Gruessner; Bellal Joseph; Randall Friese; Narong Kulvatunyou; Julie Wynne; Rifat Latifi; Peter Rhee; Terence O'Keeffe
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

6.  Treatment of severe traumatic brain injury in German pediatric intensive care units-a survey of current practice.

Authors:  A P Regensburger; V Konrad; R Trollmann; I Y Eyüpoglu; H Huebner; J Zierk; T M K Völkl; F B Fahlbusch
Journal:  Childs Nerv Syst       Date:  2019-03-02       Impact factor: 1.475

7.  Early Post-traumatic Seizure Occurrence in Pediatric Patients Receiving Levetiracetam Prophylaxis With Severe Traumatic Brain Injury.

Authors:  Meghan J Kolf; Christopher C McPherson; Kara S Kniska; Caitlyn M Luecke; Michael A Lahart; Jose A Pineda
Journal:  J Pediatr Pharmacol Ther       Date:  2020

Review 8.  Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and stroke.

Authors:  Ashok K Shetty
Journal:  Front Neurol       Date:  2013-11-04       Impact factor: 4.003

9.  Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis.

Authors:  Taolin Fang; Eduard Valdes; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2021-07-20       Impact factor: 3.210

10.  Early Use of Antiseizure Medication in Mechanically Ventilated Traumatic Brain Injury Cases: A Retrospective Pediatric Health Information System Database Study.

Authors:  Kelly D Haque; Zachary M Grinspan; Elizabeth Mauer; Marianne E Nellis
Journal:  Pediatr Crit Care Med       Date:  2021-01-01       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.